Request a FREE Sample of our FcRn Binding Kit!Request a FREE Sample of our Fc gamma RI / CD64 Binding Kit !
Happy Holiday! Limited Keychain here with your next orderHappy Holiday! Limited Keychain here with your next order
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
IT1-H82W1 | Human | Biotinylated Human Integrin alpha 4 beta 1 (ITGA4&ITGB1) Heterodimer Protein, His,Avitag™&Tag Free |
|
|
|
IT1-H52W1 | Human | Human Integrin alpha 4 beta 1 (ITGA4&ITGB1) Heterodimer Protein, His Tag&Tag Free |
|
|
Human VCAM-1, His Tag (Cat. No. VC1-H5224) immobilized on CM5 Chip can bind Biotinylated Human ITGA4&ITGB1 Heterodimer Protein, His,Avitag&Tag Free (Cat. No. IT1-H82W1) with an affinity constant of 253 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Carotegrast methyl | AJM-300 | Approved | Ea Pharma, Eisai Co Ltd | Carogra | Japan | Colitis, Ulcerative | Ea Pharma Co Ltd | 2022-03-28 | Colitis, Ulcerative | Details |
Natalizumab | BG-0002; TY-21.6; AN-10022; BG-00002; AN-100226; BG-0002-E | Approved | Biogen Inc, Perrigo Llc | Tysabri, Antegran, Antegren | Japan | Multiple Sclerosis | Biogen Inc | 2004-11-23 | Multiple Sclerosis, Relapsing-Remitting; Epilepsies, Partial; Arthritis, Rheumatoid; Graft vs Host Disease; Stroke; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis; Multiple Myeloma; Demyelinating Diseases; Myositis, Inclusion Body; Crohn Disease | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
RBx-7796 | RBx-7796 | Clinical | Sun Pharmaceutical Industries Ltd | Rhinitis, Allergic; Asthma | Details |
ATL-1102 | ATL-1102; TV-1102; ATL/TV-1102; ISIS-107248 | Phase 2 Clinical | Ionis Pharmaceuticals Inc | Multiple Sclerosis; Muscular Dystrophy, Duchenne | Details |
7HP-349 | 7HP-349; 7-HP-349 | Details | |||
Firategrast | T-0047; SB-683699 | Mitsubishi Tanabe Pharma | Details | ||
Natalizumab biosimilar (Polpharma Biologics) | PB-006 | Phase 3 Clinical | Polpharma Biologics Sa | Multiple Sclerosis, Relapsing-Remitting | Details |
LLP2A alendronate | Phase 1 Clinical | University Of California | Osteonecrosis; Bone Diseases, Metabolic; Osteoporosis; Bone Diseases | Details |
This web search service is supported by Google Inc.